Using nanotechnology to empower people worldwide with rapid, affordable, and portable diagnostic information about their own health.
Headquarters Cambridge, Massachusetts, United States
Nanobiosym Diagnostics has built and is now commercializing its FDA-authorized platform for Personalized Precision Medicine called Gene-RADAR. Harnessing more than 20 years of award-winning science and technology at the convergence of physics, nanotechnology, ICT, and biomedicine, Nanobiosym Dx is working to decentralize, democratize, mobilize, and personalize the next generation of healthcare delivery. The company aims to empower 8 billion consumers with real-time personalized mobile diagnostics and exponentially increase access to accurate diagnostics for anyone, anywhere and at any time. This includes the 4 billion people people globally who currently lack access to information about their health. Nanobiosym is part research institute and part incubator, advancing the frontiers of nanobiophysics and harnessing these innovations with novel business models and public-private partnerships to address our planet’s greatest unmet needs.
November 1, 2020
Entrepreneurship As A Force For Good
Some businesses made rapid, meaningful pivots to addressing the crises caused by COVID-19. We can help them build a better future by continuing to support them after the immediate emergency has...Read on The Atlantic »
May 27, 2020
Precision Mobile Testing Is Key to Opening the Economy Safely
Fighting COVID-19 with our antiquated paradigm of centralized health care delivery is like fighting World War III with a musketRead on Scientific American Blog Network »
More Ventures in Health
Get the Unreasonable Newsletter
Get twice-monthly updates on Nanobiosym and over 372 other ventures working to solve the world's toughest problems.
Must select the list to subscribe to.